BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20650075)

  • 1. Differential effects of chemical irritants in rabbit and human skin organ cultures.
    van de Sandt JJ; Rutten AA
    Toxicol In Vitro; 1995 Apr; 9(2):157-68. PubMed ID: 20650075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of arachidonic and linoleic acid metabolites in skin organ cultures as characteristics of in vitro skin irritancy.
    van de Sandt JJ; Maas WJ; Doornink PC; Rutten AA
    Fundam Appl Toxicol; 1995 Apr; 25(1):20-8. PubMed ID: 7601324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test.
    Spielmann H; Hoffmann S; Liebsch M; Botham P; Fentem JH; Eskes C; Roguet R; Cotovio J; Cole T; Worth A; Heylings J; Jones P; Robles C; Kandárová H; Gamer A; Remmele M; Curren R; Raabe H; Cockshott A; Gerner I; Zuang V
    Altern Lab Anim; 2007 Dec; 35(6):559-601. PubMed ID: 18186667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro model for detecting skin irritants: methyl green-pyronine staining of human skin explant cultures.
    Jacobs JJ; Lehé C; Cammans KD; Das PK; Elliott GR
    Toxicol In Vitro; 2002 Oct; 16(5):581-8. PubMed ID: 12206825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals.
    Eskes C; Cole T; Hoffmann S; Worth A; Cockshott A; Gerner I; Zuang V
    Altern Lab Anim; 2007 Dec; 35(6):603-19. PubMed ID: 18186668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and evaluation of immortalized human epidermal keratinocytes for an alternative skin irritation test.
    Kim CW; Kim CD; Choi KC
    J Pharmacol Toxicol Methods; 2017; 88(Pt 2):130-139. PubMed ID: 28827132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The living skin equivalent as a model in vitro for ranking the toxic potential of dermal irritants.
    Gay R; Swiderek M; Nelson D; Ernesti A
    Toxicol In Vitro; 1992 Jul; 6(4):303-15. PubMed ID: 20732127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests--an assessment of the performance of the optimised test.
    Kandárová H; Liebsch M; Gerner I; Schmidt E; Genschow E; Traue D; Spielmann H
    Altern Lab Anim; 2005 Aug; 33(4):351-67. PubMed ID: 16185104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an in vitro corrosion/irritation prediction assay using the EpiDerm skin model.
    Kidd DA; Johnson M; Clements J
    Toxicol In Vitro; 2007 Oct; 21(7):1292-7. PubMed ID: 17936572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of fibrin-based dermal-epidermal organotypic cultures for in vitro skin corrosion and irritation testing of chemicals according to OECD TG 431 and 439.
    Morales M; Pérez D; Correa L; Restrepo L
    Toxicol In Vitro; 2016 Oct; 36():89-96. PubMed ID: 27448499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of human and rat keratinocyte cultures to assess skin irritation potential.
    Lawrence JN; Starkey S; Dickson FM; Benford DJ
    Toxicol In Vitro; 1996 Jun; 10(3):331-40. PubMed ID: 20650213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin.
    Wilmer JL; Burleson FG; Kayama F; Kanno J; Luster MI
    J Invest Dermatol; 1994 Jun; 102(6):915-22. PubMed ID: 8006454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols.
    Tornier C; Rosdy M; Maibach HI
    Toxicol In Vitro; 2006 Jun; 20(4):401-16. PubMed ID: 16229985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro skin irritation of chemicals: optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process.
    Cotovio J; Grandidier MH; Portes P; Roguet R; Rubinstenn G
    Altern Lab Anim; 2005 Aug; 33(4):329-49. PubMed ID: 16185103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of interleukin-1alpha (IL-1alpha) and interleukin-8 (IL-8) expression and release in in vitro reconstructed human epidermis for the prediction of in vivo skin irritation and/or sensitization.
    Coquette A; Berna N; Vandenbosch A; Rosdy M; De Wever B; Poumay Y
    Toxicol In Vitro; 2003 Jun; 17(3):311-21. PubMed ID: 12781210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin irritant-induced cytotoxicity and prostaglandin E(2) release in human skin keratinocyte cultures.
    Lawrence JN; Dickson FM; Benford DJ
    Toxicol In Vitro; 1997 Oct; 11(5):627-31. PubMed ID: 20654361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A catch-up validation study on reconstructed human epidermis (SkinEthic RHE) for full replacement of the Draize skin irritation test.
    Alépée N; Tornier C; Robert C; Amsellem C; Roux MH; Doucet O; Pachot J; Méloni M; de Brugerolle de Fraissinette A
    Toxicol In Vitro; 2010 Feb; 24(1):257-66. PubMed ID: 19733228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of SV40 T-transformed human corneal epithelial cells to evaluate potential irritant chemicals for in vitro alternative eye toxicity.
    Kim CW; Park GT; Bae ON; Noh M; Choi KC
    J Pharmacol Toxicol Methods; 2016; 80():82-9. PubMed ID: 27233534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the medical devices benchmark materials in the controlled human patch testing and in the RhE in vitro skin irritation protocol.
    Kandárová H; Bendova H; Letasiova S; Coleman KP; De Jong WH; Jírova D
    Toxicol In Vitro; 2018 Aug; 50():433-438. PubMed ID: 29462660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SkinEthic™ RHE for in vitro evaluation of skin irritation of medical device extracts.
    Pellevoisin C; Videau C; Briotet D; Grégoire C; Tornier C; Alonso A; Rigaudeau AS; Bouez C; Seyler N
    Toxicol In Vitro; 2018 Aug; 50():418-425. PubMed ID: 29339149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.